HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Wayne L. Hofstetter Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hofstetter, W. L. Search for Related Content PubMed PubMed Citation Articles by Hofstetter, W. L. Related Collections Esophagus - cancer Related Article

---

Original Articles: General Thoracic

Invited Commentary

Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 445, Houston, TX  77030-4009

(Email: whofstetter@mdanderson.org).

The first 20% of the full text of this article appears below.

The results of this study by Cao and colleagues [1] indicate that PTPN12 expression evaluated by immunohistochemistry analysis can be categorized into low and high dichotomous variables and that these variables independently correlate with survival outcomes. As indicated, the results are mainly relevant in the subgroup of patients who were American Joint Committee on Cancer, Seventh Edition, stage II, but they do not really apply to the more advanced subgroup of stage III patients.

For reasons that are unknown to . . . [Full Text of this Article]

Related Article

Tyrosine-Protein Phosphatase Nonreceptor Type 12 Is a Novel Prognostic Biomarker for Esophageal Squamous Cell Carcinoma

Xun Cao, Yong Li, Rong-Zhen Luo, Li-Ru He, Juan Yang, Mu-Sheng Zeng, and Zhe-Sheng Wen
Ann. Thorac. Surg. 2012 93: 1674-1680. [Abstract] [Full Text] [PDF]